Urinary Trypsin Inhibitor Fragment

• UNSPSC Description:

  Urinary Trypsin Inhibitor Fragment is a fragment derived from urinary trypsin inhibitor by proteolysis. Urinary Trypsin Inhibitor Fragment can inhibit tumor cell invasion by limited proteolysis[1].

• Target Antigen:

  Ser/Thr Protease

• Type:

  Biochemical Assay Reagents

• Related Pathways:

  Metabolic Enzyme/Protease

• Applications:

  Cancer-Kinase/protease

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/urinary-trypsin-inhibitor-fragment.html

• Solubility:

  10 mM in DMSO

• Smiles:

  CC[C@H](C)[C@@H](C(O)=O)NC([C@H](CC1=CC=CC=C1)NC([C@H](C)NC([C@H](CCCNC(N)=N)NC([C@H](CS)NC([C@H]2N(CCC2)C(CNC([C@@H](N)CCCNC(N)=N)=O)=O)=O)=O)=O)=O)=O

• Molecular Weight:

  919.11

• References & Citations:

  [1]Kobayashi H, et, al. Urinary trypsin inhibitor (UTI) and fragments derived from UTI by limited proteolysis efficiently inhibit tumor cell invasion. Clin Exp Metastasis. 1994 Mar;12(2):117-28.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  164859-77-2